241 related articles for article (PubMed ID: 37843733)
1. Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study.
Elmoghayer ME; Saleh NM; Abu Hashim II
Drug Deliv Transl Res; 2024 Apr; 14(4):895-917. PubMed ID: 37843733
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery.
Zhang P; Liu X; Hu W; Bai Y; Zhang L
Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746
[TBL] [Abstract][Full Text] [Related]
3. Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.
Wu J; Shen Q; Fang L
Drug Dev Ind Pharm; 2013 Jul; 39(7):1010-9. PubMed ID: 22681515
[TBL] [Abstract][Full Text] [Related]
4. Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Ibrutinib Delivery: A Potential Nanoformulation of Novel Kinase Inhibitor.
Zhao L; Tang B; Tang P; Sun Q; Suo Z; Zhang M; Gan N; Yang H; Li H
J Pharm Sci; 2020 Feb; 109(2):1136-1144. PubMed ID: 31606544
[TBL] [Abstract][Full Text] [Related]
5. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T
Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293
[TBL] [Abstract][Full Text] [Related]
6. Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery.
Ricci F; Racaniello GF; Lopedota A; Laquintana V; Arduino I; Lopalco A; Cutrignelli A; Franco M; Sigurdsson HH; Denora N
Int J Pharm; 2022 Jun; 622():121905. PubMed ID: 35697201
[TBL] [Abstract][Full Text] [Related]
7. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes.
Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F
Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666
[TBL] [Abstract][Full Text] [Related]
8. Drug-in-cyclodextrin-in-polymeric nanoparticles: A promising strategy for rifampicin administration.
Abruzzo A; Croatti V; Zuccheri G; Pasquale Nicoletta F; Sallustio V; Corazza E; Vitali B; Cerchiara T; Luppi B; Bigucci F
Eur J Pharm Biopharm; 2022 Nov; 180():190-200. PubMed ID: 36210035
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery.
Khalil SK; El-Feky GS; El-Banna ST; Khalil WA
Carbohydr Polym; 2012 Oct; 90(3):1244-53. PubMed ID: 22939337
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides.
Trapani A; Lopedota A; Franco M; Cioffi N; Ieva E; Garcia-Fuentes M; Alonso MJ
Eur J Pharm Biopharm; 2010 May; 75(1):26-32. PubMed ID: 20102738
[TBL] [Abstract][Full Text] [Related]
11. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol.
Deng F; Hu W; Chen H; Tang Y; Zhang L
Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869
[TBL] [Abstract][Full Text] [Related]
12. Dimethyl-β-cyclodextrin/salazosulfapyridine inclusion complex-loaded chitosan nanoparticles for sustained release.
Tang P; Yang H; Tang B; Wu D; Du Q; Xu K; Li H
Carbohydr Polym; 2017 Jan; 156():215-222. PubMed ID: 27842816
[TBL] [Abstract][Full Text] [Related]
13. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
14. Preparation, Characterization, and
Zhang Z; Chen J; Zou L; Tang J; Zheng J; Luo M; Wang G; Liang D; Li Y; Chen B; Yan H; Ding W
Int J Nanomedicine; 2022; 17():5287-5302. PubMed ID: 36411767
[TBL] [Abstract][Full Text] [Related]
15. Cyclodextrin/chitosan nanoparticles for oral ovalbumin delivery: Preparation, characterization and intestinal mucosal immunity in mice.
He M; Zhong C; Hu H; Jin Y; Chen Y; Lou K; Gao F
Asian J Pharm Sci; 2019 Mar; 14(2):193-203. PubMed ID: 32104451
[TBL] [Abstract][Full Text] [Related]
16. pH and temperature stability of (-)-epigallocatechin-3-gallate-β-cyclodextrin inclusion complex-loaded chitosan nanoparticles.
Liu F; Majeed H; Antoniou J; Li Y; Ma Y; Yokoyama W; Ma J; Zhong F
Carbohydr Polym; 2016 Sep; 149():340-7. PubMed ID: 27261758
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W
Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276
[TBL] [Abstract][Full Text] [Related]
18. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
19. Sulfobutylether-β-cyclodextrin: A functional biopolymer for drug delivery applications.
Pardeshi CV; Kothawade RV; Markad AR; Pardeshi SR; Kulkarni AD; Chaudhari PJ; Longhi MR; Dhas N; Naik JB; Surana SJ; García MC
Carbohydr Polym; 2023 Feb; 301(Pt B):120347. PubMed ID: 36446486
[TBL] [Abstract][Full Text] [Related]
20. Sulfobutylether-β-cyclodextrin/chitosan nano- and microparticles and their physicochemical characteristics.
Fülöp Z; Saokham P; Loftsson T
Int J Pharm; 2014 Sep; 472(1-2):282-7. PubMed ID: 24971695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
